Alpine Global Management, LLC Immunome Inc. Transaction History

Alpine Global Management, LLC

$331 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.54 - $22.11 $1.05 Million - $2.01 Million	-91,119 Reduced 64.03%	51,178 $619,000
Q1 2024 May 15, 2024	SELL	$11.01 - $27.34 $550,896 - $1.37 Million	-50,036 Reduced 26.02%	142,297 $3.51 Million
Q4 2023 Aug 06, 2024	SELL	$7.3 - $10.73 $1.27 Million - $1.86 Million	-173,638 Reduced 47.45%	192,333 $2.06 Million
Q4 2023 Feb 12, 2024	SELL	$7.3 - $10.73 $1.27 Million - $1.86 Million	-173,638 Reduced 47.45%	192,333 $2.06 Million
Q2 2023 Aug 06, 2024	BUY	$4.7 - $7.91 $1.05 Million - $1.77 Million	223,674 Added 157.19%	365,971 $2.89 Million
Q1 2023 May 15, 2023	SELL	$3.26 - $5.69 $1.15 Million - $2 Million	-352,264 Reduced 49.05%	365,971 $1.83 Million
Q3 2022 Nov 14, 2022	BUY	$3.39 - $6.14 $2.43 Million - $4.41 Million	718,235 New	718,235 $3.19 Million
Q2 2022 Aug 15, 2022	SELL	$2.24 - $5.79 $356,160 - $920,610	-159,000 Reduced 18.13%	718,235 $2.31 Million
Q1 2022 May 16, 2022	BUY	$3.88 - $13.99 $495,774 - $1.79 Million	127,777 Added 17.05%	877,235 $5.09 Million
Q1 2022 May 13, 2022	SELL	$3.88 - $13.99 $437,326 - $1.58 Million	-112,713 Reduced 13.07%	749,458 $4.36 Million
Q4 2021 Feb 14, 2022	BUY	$12.96 - $23.44 $97,200 - $175,800	7,500 Added 0.88%	862,171 $11.2 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $32.33 $962,849 - $1.91 Million	58,962 Added 7.41%	854,671 $14.8 Million
Q1 2021 May 13, 2021	BUY	$9.56 - $43.24 $52,589 - $237,863	5,501 Added 0.7%	795,709 $27 Million
Q4 2020 Feb 12, 2021	BUY	$9.46 - $14.16 $7.48 Million - $11.2 Million	790,208 New	790,208 $7.65 Million

Others Institutions Holding IMNM

# of Institutions

121

Shares Held

47.1M

Call Options Held

322K

Put Options Held

1.91M

T. Rowe Price Investment Management, Inc. Baltimore, MD

5.76M
Shares

$63.2 Million
0.05% of portfolio
Redmile Group, LLC San Francisco, CA

4.89M
Shares

$53.6 Million
4.67% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.88M
Shares

$42.6 Million
2.46% of portfolio
Black Rock Inc. New York, NY

3.76M
Shares

$41.2 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

3.49M
Shares

$38.3 Million
0.03% of portfolio

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $133M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Account